Table 2.
Patient characteristics
| Patient characteristics | No. of patients (%) n = 14 |
|---|---|
| Sex Male Female |
4 (28.6) 10 (71.4) |
| Age Median age, years (range) |
54,5 (35–72) |
| ECOG performance status O 1 2 |
8 (57.1) 5 (35.7) 1 (7.1) |
| Primary tumor location Breast Rectum Stomach Othersa |
5 (35.7) 3 (21.4) 3 (21.4) 3 (21.4) |
| No. of organs involved (primary excluded) 1 2 3 ≥4 |
5 (35.7) 3 (21.4) 2 (14.3) 4 (28.6) |
| Organs involved (primary tumor excluded) Lymph nodes Lung Liver Abdominal Wall Bone Othersb |
7 (50.0) 5 (35.7) 3 (21.4) 3 (21.4) 3 (21.4) 10 (71.4) |
| Her2 status IHC 2+/ISH+ IHC 3+ |
3 (21.4) 11 (78.6) |
Abbreviations: ECOG Eastern Cooperative Oncology Group, IHC immunohistochemistry, ISH in-situ hybridisation
aOthers: head and neck (2 pts), pancreas (1 pt)
bOthers: adrenal gland, spleen, bladder, lymphangiosis carcinomatosa, pleura, peritoneum, chest wall, brain, skin